Member Info for stephen11

Signs of a good day for the SP.

What did the Arabs say Jay?…I don’t have LinkedIn

The future is never clear.

"Uncertainty actually is the friend of the buyer of long-term values."

The long term holders know the true value of this stock.

Hold the line - good times ahead.

Stephen11.

I have about 30 UK based companies on my watchlist and almost all are in the red today. The current GDR Sp does not necessarily represent the pump and dump that some have suggested.

Kantar published figures today indicating that food inflation has risen to almost 17% in the UK. This erodes confidence in spending generally and on shares in particular. People cut there cloth to fit and budget accordingly. The person who purchases (X) amount of shares each month when his wages come in might be thinking twice! This could be partially to blame for the drop.

The fundamentals remain the same for GDR and i'm here for the long haul. All to play for.

Keep the faith.

Stephen11.

Can't go wrong with either option Upwards

We’re off to the races today again!

Happy days.

This would be the dream - heavy buying this week due to the herd taking positions before NICE news.

Then, when NICE news hits??????

Stephen11.

Very true Laverda - I know where I’ll be putting the rest of this years and next years ISA allowance. I don’t want to miss the boat - 0.5 will be history very soon and 0.8 - 1p won’t be a mystery!

GLA.

Stephen11.

I’m going to give the end of next week a new name.

50p Friday

NICE - tantalisingly close!

Lol.

He'll be catching a ride on Virgin Galactica

They can't catch this share - its gone from the slow lane of the motorway to supersonic!

Showing +30%

All bets are off.

Who knows were we could end up at 4.30pm

Pleased for everyone - especially the long term holders.

Stephen11.

UP 23% for the day!

Is the rocket ready BigAl?

I have a jar in the kitchen. When i have to many 5, 2, and 1p in my wallet i throw them into said jar.

If a big pharma company wanted GDR, this is all they would need to do - delve into there small change. They work in a different league to AIM listed companies - 300 million is small change to the likes of Astra Zeneca - its piggy bank money.

100% agree with comments below.

Stephen11.

The sleeping giant has woken!

Hello Folks,

I read, with interest, the anticipation of NICE news in February. I don't know if this will lead to automatic sales and rollout in the UK, though i'd like to think it will put us in a stronger position than before.

Additionally, the hearing loss study results have already been published in a widely respected journal. Surely this should carry some wait with the buyers and powers that be?

JAMA Pediatrics article as below:

https://jamanetwork.com/journals/jamapediatrics/fullarticle/2790066

Best wishes,

Stephen11.

Hello Aim,

If you go into the Genedrive website the various financial reports would be your best bet if you are wanting to learn about the product portfolio. They usually do a rundown in each presentation.

I'll post the relevant journal articles related to the hearing loss products aswell.

Stephen11.

Somethings afoot?

I would suggest there will be a bit of an overhang going into tomorrow morning - things could get spicey!

Wouldn't want to be out for an hour, never mind the weekend.

LOL

Stephen11.

Get in while you still can - the 20s will be history soon.

What will this share SP be on any of the predicted news below:

* Hearing Loss Product MT-RNR1

- News due in Q1 2023 about the NICE accelerated evaluation of the Genedrive MT-RNR1 ID test (February, 2023)
- Global Market said to be worth in access of £100m
- 2 other Health Trusts in the North-West of England said to be in the training and install process of the hearing loss product (news may drop this month)
- 8 more clusters/Health Trusts in the near-time sales funnel for the UK
- Working with 22 distribution partners world wide
- Of the 22; 2 have been confirmed (Inspirational Healthcare and 1 in Spain). 3 partners are in due diligence/negotiation stage. 5 partners are beginning the negotiation stage
- 3 of the new partners operate outside of the UK
- Filed US FDA PRE-SUB for the Genedrive MT-RNR1 ID product range (First meeting with the FDA scheduled for December, 2022). Hopefully we'll get news very soon

*Stroke Marker Test CYP2C19
- NICE has included CYP2C19 Stroke Marker test on the new diagnostic assessment programme
- Targeting UK launch March/April 2023 through UKCA mark
- Extremely lucrative market worldwide
- In America for a less accurate product, health insurance companies pay the hospitals around $250 per test

AOB

- Funding and grant applications in place. These can be very lucrative - I remember we got $1m from the US DOD

Good Luck everyone.

Stephen11.

Showing as 14.28% up on Hargreaves Lansdown and 23p to buy atm